# Bryostatin 1 in Treating Patients With Relapsed Multiple Myeloma

> **NCT00002907** · PHASE2 · COMPLETED · sponsor: **Barbara Ann Karmanos Cancer Institute**

## Conditions studied

- Multiple Myeloma and Plasma Cell Neoplasm

## Interventions

- **DRUG:** bryostatin 1

## Key facts

- **NCT ID:** NCT00002907
- **Lead sponsor:** Barbara Ann Karmanos Cancer Institute
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1997-01
- **Primary completion:** 1999-01
- **Final completion:** 2000-11
- **Target enrollment:** — (—)
- **Last updated:** 2013-04-05

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00002907

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00002907, "Bryostatin 1 in Treating Patients With Relapsed Multiple Myeloma". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT00002907. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*